What the evidence shows for the indications licensed in the Netherlands The SURMOUNT-1 trial, which underpinned the weight-management authorisation, enrolled 2,539 adults with obesity but without type-2 diabetes and reported a mean body-weight reduction of 20.9% at 72 weeks on tirzepatide 15 mg weekly versus 3.1% on placebo [4]
The results of these analyses, after excluding RCTs with a primary endpoint other than body weight reduction 17,18,30,41,42,43,44 , are reported in Table 3
Medical Weight Loss Our structured metabolic programs at our weight loss clinic in Stuart, FL utilize GLP-1 therapies such as Semaglutide and Tirzepatide, which is highly sought after in Stuart, Florida
In a 2026 JAMA secret-shopper study, a slender Yale medical student posed as a 237-pound patient and attempted to obtain semaglutide or tirzepatide from 49 direct-to-consumer websites
Common examples include side effects, insurance coverage changes, and availability issues
Most Common Side Effects Clinical trials show that the most frequently reported side effects include: Nausea Vomiting Decreased appetite Diarrhea Abdominal (stomach) pain Constipation These gastrointestinal issues happen because Ozempic slows down stomach emptying
